Experts worry European laws restricting emission limits for medical staff will hurt research and harm patients.

By 2008, it will be illegal for workers to be exposed to electromagnetic fields higher than 300GHz

The number of confirmed cases of E.coli food poisoning in south Wales valleys has risen to 31 people in 16 schools.

As food suppliers face examination by investigators, there are fears the infections might increase

The U.S. Food and Drug Administration says warnings to drug companies regarding misleading advertisements have more than tripled in the last year.

Thomas Abrams, head of FDA's Division of Drug Marketing and Communications says, the agency sent 17 warning letters in the 12 months ending in August compared with an average of about four to five letters in recent years

A survey by The Washington Post

A random survey of 680 adult evacuees staying in shelters in the Houston area from Sept. 10 to 12 found that 52 percent had no health insurance coverage at the time of the hurricane. Of those with coverage, 34 percent say it is through Medicaid and 16 percent through Medicare

The Food and Drug Administration (FDA) approves a new biologic treatment to treat ulcerative colitis. Manufacturer Centocor, Inc. announces that Remicade has received the green light to treat the chronic inflammatory bowel disease.

Remicade's efficiency in the treatment of inflammatory bowel disease is well established. It was first approved in the United States for the treatment of Crohn's disease in 1998.Remicade remains to this day the only anti-tumor necrosis factor therapy indicated for the treatment of Chron's. With this new approval for the treatment of ulcerative colitis, Remicade is now the only biologic indicated for the treatment of both types of inflammatory bowel diseases